GSK Plc (GSK)
50.05
+1.92
(+3.99%)
USD |
NYSE |
Sep 14, 16:00
50.00
-0.05
(-0.10%)
After-Hours: 20:00
GSK Price to Book Value : 4.323 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 4.323 |
| September 11, 2026 | 4.157 |
| September 10, 2026 | 4.156 |
| September 09, 2026 | 4.200 |
| September 08, 2026 | 4.192 |
| September 04, 2026 | 4.309 |
| September 03, 2026 | 4.394 |
| September 02, 2026 | 4.356 |
| September 01, 2026 | 4.375 |
| August 31, 2026 | 4.34 |
| August 28, 2026 | 4.389 |
| August 27, 2026 | 4.342 |
| August 26, 2026 | 4.442 |
| August 25, 2026 | 4.497 |
| August 24, 2026 | 4.472 |
| August 21, 2026 | 4.527 |
| August 20, 2026 | 4.488 |
| August 19, 2026 | 4.567 |
| August 18, 2026 | 4.418 |
| August 17, 2026 | 4.343 |
| August 14, 2026 | 4.277 |
| August 13, 2026 | 4.357 |
| August 12, 2026 | 4.344 |
| August 11, 2026 | 4.396 |
| August 10, 2026 | 4.505 |
| Date | Value |
|---|---|
| August 07, 2026 | 4.574 |
| August 06, 2026 | 4.506 |
| August 05, 2026 | 4.444 |
| August 04, 2026 | 4.451 |
| August 03, 2026 | 4.449 |
| July 31, 2026 | 4.464 |
| July 30, 2026 | 4.497 |
| July 29, 2026 | 4.596 |
| July 28, 2026 | 4.639 |
| July 27, 2026 | 4.489 |
| July 24, 2026 | 4.435 |
| July 23, 2026 | 4.382 |
| July 22, 2026 | 4.384 |
| July 21, 2026 | 4.386 |
| July 20, 2026 | 4.322 |
| July 17, 2026 | 4.470 |
| July 16, 2026 | 4.558 |
| July 15, 2026 | 4.444 |
| July 14, 2026 | 4.426 |
| July 13, 2026 | 4.516 |
| July 10, 2026 | 4.558 |
| July 09, 2026 | 4.532 |
| July 08, 2026 | 4.536 |
| July 07, 2026 | 4.605 |
| July 06, 2026 | 4.585 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 10.73 |
| Eli Lilly & Co. | 31.63 |
| Merck & Co., Inc. | 8.528 |
| Novo Nordisk A/S | 5.675 |
| Novartis AG | 6.125 |
Price to Book Value Related Metrics
| PE Ratio | 15.77 |
| PS Ratio | 2.292 |
| PEG Ratio | 0.3289 |
| Price to Free Cash Flow | 15.43 |
| Price | 50.05 |
| Earnings Yield | 6.34% |
| Market Cap | 101.24B |
| PEGY Ratio | 0.3055 |
| Operating PE Ratio | 9.168 |
| Normalized PE Ratio | 10.85 |